In contrast to recent data from Thike and colleagues [24], AR status did not modify Core Basal patient prognosis, suggesting that a multi-Institutional series of cases with definition of TNBC subtypes should further investigate implications of AR deregulation n in this specific cancer subset. This evidence concerns the gene AR and cancer.